Results are based on the Symptom Checklist-90-Revised (SCL-90-R), a 90-item multidimensional self-report symptom inventory using a 5-point rating scale
The companies that are correctly positioned in this environment are those with robust pipeline depth, manufacturing efficiency advantages, and therapeutic areas where generic competition dynamics are unfavorable to Cost Plus-style pricing primarily biologics, where the regulatory and manufacturing complexity of biosimilar development creates slower and less complete price erosion than small-molecule generics experience
Strategy 4: topical interventions While addressing the root cause nutritionally is primary, topical interventions can provide additional support for follicles under stress
Posts may contain misinformation, typos, or incomplete descriptions
It can also increase the risk of pancreatitis, bowel obstruction, and gastroparesis (stomach paralysis)
Here are five articles to explore: Interrogating the Molecular Mechanisms of Hyperuricemic Nephropathy: Impact of Loop Diuretics on Long-Term Kidney Outcome: A Post Hoc Analysis of the STOPAngiotensin-Converting Enzyme Inhibitor Trial: Measurement Properties of an Electronic Patient-Reported Outcome Measure for Patients with NonDialysis-Dependent CKD: Ergothioneine Depletion in Peritoneal Dialysis: Design and Implementation of a Universal Donor Kidney: Explore the full issue of Kidney360: To view or add a comment, sign in New Currents Literature Watch explores evidence linking clopidogrel use with PCABs or PPIs to increase ischemic risk in stroke patients
